Back to Authors

Der-Torossian, Hirak

Mayo Clinic

From the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (R.Y.); Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill (J.W.); Sarah Cannon Research Institute, Tennessee Oncology, Nashvill

Citations 1

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C

New England Journal of Medicine | December 21, 2022 | Volume: 388 | Issue: 1 | Pages: 44-54

10.1056/nejmoa2212419 | PMID 36546659